1. Not only in silico drug discovery: Molecular modeling towards in silico drug delivery formulations
- Author
-
Tommaso Casalini
- Subjects
0303 health sciences ,Molecular model ,Mechanism (biology) ,Computer science ,Drug discovery ,Scale (chemistry) ,In silico ,Drug Compounding ,Rational design ,Pharmaceutical Science ,02 engineering and technology ,Molecular Dynamics Simulation ,021001 nanoscience & nanotechnology ,Ligands ,03 medical and health sciences ,Pharmaceutical Preparations ,Drug delivery ,Drug Discovery ,Nanomedicine ,Biochemical engineering ,0210 nano-technology ,030304 developmental biology - Abstract
The use of methods at molecular scale for the discovery of new potential active ligands, as well as previously unknown binding sites for target proteins, is now an established reality. Literature offers many successful stories of active compounds developed starting from insights obtained in silico and approved by Food and Drug Administration (FDA). One of the most famous examples is raltegravir, a HIV integrase inhibitor, which was developed after the discovery of a previously unknown transient binding area thanks to molecular dynamics simulations. Molecular simulations have the potential to also improve the design and engineering of drug delivery devices, which are still largely based on fundamental conservation equations. Although they can highlight the dominant release mechanism and quantitatively link the release rate to design parameters (size, drug loading, et cetera), their spatial resolution does not allow to fully capture how phenomena at molecular scale influence system behavior. In this scenario, the “computational microscope” offered by simulations at atomic scale can shed light on the impact of molecular interactions on crucial parameters such as release rate and the response of the drug delivery device to external stimuli, providing insights that are difficult or impossible to obtain experimentally. Moreover, the new paradigm brought by nanomedicine further underlined the importance of such computational microscope to study the interactions between nanoparticles and biological components with an unprecedented level of detail. Such knowledge is a fundamental pillar to perform device engineering and to achieve efficient and safe formulations. After a brief theoretical background, this review aims at discussing the potential of molecular simulations for the rational design of drug delivery systems., Journal of Controlled Release, 332, ISSN:0168-3659, ISSN:1873-4995
- Published
- 2021